Concepedia

Joseph Piraino

JP

4

Publications

531

Citations

4

H-Index

2009

Active since

Affiliations

Pfizer (United States)(Current)

Joseph Piraino is an author at Pfizer (United States) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

2009–2014

4

Publications

4

Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth

Brion W. Murray, Chuangxing Guo, Joseph Piraino et al. · Proceedings of the National Academy of Sciences · 2010 · 318 citations · Full text

Structure-based design of novel human Pin1 inhibitors (I)

Chuangxing Guo, Xinjun Hou, Liming Dong et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 105 citations · Full text

, , +4

Discovery of Pyrroloaminopyrazoles as Novel PAK Inhibitors

Chuangxing Guo, Indrawan McAlpine, Junhu Zhang et al. · Journal of Medicinal Chemistry · 2012 · 59 citations · Full text

, , +15

Structure-based design of novel human Pin1 inhibitors (III): Optimizing affinity beyond the phosphate recognition pocket

Chuangxing Guo, Xinjun Hou, Liming Dong et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 49 citations · Full text

, , +8

Rows per page

1–4 of 4